“Boris Johnson, waive vaccine patents” projected onto Tory conference
Date: 3 October 2021
Vaccine access campaigners have told Boris Johnson that 10,000 people are dying every day while he disrupts efforts to allow low and middle income countries to produce their own vaccines, projecting a message onto One Manchester Tower as the Conservative Party’s annual conference begins.
The People’s Vaccine Alliance projected “The world is watching. 10,000 people die every day from Covid-19 while the UK defends vaccine monopolies. Boris Johnson, waive vaccine patents and vaccinate the world” onto a building just metres away from the conference hall.
High resolution pictures available here (Credit: POW): https://www.dropbox.com/sh/m7nb4hghxeaj12s/AAASXsL41E4h0KuRHJHoJN5Sa?dl=0
It comes as the world marks one year that the UK has blocked attempts to waive intellectual property on Covid-19 vaccines, tests and treatments at the World Trade Organisation (WTO). A shocking 3.5 million people have died from COVID-19 while the UK has blocked the waiver.
India and South Africa first proposed the waiver on 2 October 2020, which would remove patent and trade secret barriers allowing more manufacturers to begin producing COVID-19 tools without fear of infringing on big pharmaceutical companies’ intellectual property rights. After receiving near-unanimous support from low- and middle-income countries, the United States threw its weight behind the Waiver in May 2021, while Australia announced its support last month.
Germany has forced EU opposition to the Waiver, despite support from countries including France. But with post-election coalition talks likely to bring a change in government in Germany, the UK could be the last opponent to the Waiver at the WTO.
Campaigners are calling for the government to stop opposing the waiver when the WTO’s intellectual property council meets tomorrow. They also want the government to force pharmaceutical companies to share their vaccine technology and know-how with the World Health Organisation, so that other manufacturers can produce Covid-19 vaccines, tests and treatments.
Just 1% of people in low-income countries are fully vaccinated. Many countries are left waiting for donations while rich countries roll out third jabs to their already fully vaccinated populations.
Nick Dearden, Director of Global Justice Now, said:
“10,000 people die every day that the UK continues to block a vaccine intellectual property waiver at the World Trade Organisation. Each one of those deaths should be a stain on the conscience of the Prime Minister.
“Right now, Boris Johnson is enforcing a system of vaccine apartheid. At Conservative Party conference this week, he must finally get out of the way of countries producing their own vaccine. Failing to act will shame the UK for a generation or more.”
Saoirse Fitzpatrick, Advocacy Manager at STOPAIDS, said:
“The UK government says that ‘no one is safe until everyone is safe’ but they’ve bought the lion’s share of doses and now they’re blocking other countries from producing their own. This is highly dangerous as unequal vaccination risks new variants developing.
The UK Government must tackle COVID-19 monopolies and push pharmaceutical companies to share their manufacturing know-how through the World Health Organisation. The Oxford/AstraZeneca vaccine was 97% publicly funded, – including a significant contribution from UK taxpayers. The Government must work with AstraZeneca and the WHO to make this vaccine a global public good.”
Anna Marriot, Health Policy Manager at Oxfam, said:
“It is unacceptable for the UK government to continue standing in the way of willing, qualified, and capable manufacturers across the world who can make the vaccines needed to ensure everyone is protected and bring this pandemic to an end.
“Vaccine monopolies are earning pharmaceutical corporations billions in profit at the cost of lives and livelihoods every day. Support for this waiver would also protect people in the UK – vaccine scarcity in the rest of the world prolongs the pandemic, escalates the risk of vaccine resistant variants, and continues to cause massive economic disruption and loss to UK businesses.”
A TRIPS waiver would help enable a scale-up of vaccine manufacturing and distribution in low- and middle- income countries, who are in desperate need of the vaccine.
3 million people globally have signed petitions calling for a ‘people’s vaccine’, yet the UK government has failed to listen.
The UK and other rich country governments are failing to exert influence over pharmaceutical companies to share critical technology and know-how to enable independent, wide-scale vaccine production by capable companies in developing countries.
Boris Johnson failed to make an appearance at Biden’s virtual summit last week, an event which laid out the US strategy for ending COVID-19 and building better health security to prevent and prepare for future pandemics. Yet there was no avoiding today’s message, projecting down onto Tory MPs, that “no one is safe until everyone is safe”.
The People’s Vaccine alliance have outlined clear instructions for the Prime Minister: share vaccine technology and ensure pharmaceutical companies do the same; waive intellectual property rights; and reallocate vaccine doses immediately. As two large eyes peer down over Manchester central convention complex, there is no mistaking the message that the world is watching, and waiting.
Notes to editor:
According to Oxford University’s Our World in Data, 3.72 million people have died from Covid-19 since 2 October 2020, when India and South Africa first proposed a waiver of intellectual property rules on Covid-19 vaccines and treatments: https://ourworldindata.org/covid-deaths
As of 2 October 2021, an average of 10,192 people have died across the 365 days since the proposal was put forward.
The People’s Vaccine Alliance is a coalition of 76+ organisations including Oxfam, Global Justice Now and STOPAIDS.
The People’s Vaccine alliance (PVA) have five urgent demands for the UK government: commit to a global plan to vaccinate 70 per cent by the middle of 2022; share vaccine technology and require pharmaceutical companies to do the same; waive intellectual property rights; invest public funding to increase vaccine R&D and manufacturing capacity in lower-income countries; and reallocate vaccine doses immediately.
For further comment or to arrange an interview, please contact: Saoirse Fitzpatrick – firstname.lastname@example.org